Philogen SpA raises 62 mln euros
Philogen SpA said May 13 that it raised 62 million euros ($69.7 million) in financing from new and private investors. Philogen is a clinical-stage biotechnology company focused on antibody-based therapeutics.
13 May 2019•3 mins read
